Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
GUTSthis companyFractyl Health, Inc.	$0.89	-2.39×	35.68×	0×	-2.27×	52.9%	0.0%	0.0%	0.0%	-1490.3%	-89.5%	-26.9%	6.52×	0.14×	0×	4.78×	0.0%	2	-13.45	2	C+
ALXOALX Oncology Holdings Inc.	$1.22	-0.59×	2.33×	0×	-0.5×	-90.6%	0.0%	0.0%	0.0%	-391.4%	-262.0%	-139.1%	0.2×	0.11×	-64.93×	2.07×	0.0%	2	-2.66	2	C
ARTVArtiva Biotherapeutics, Inc.	$4.21	-1.25×	0.95×	0×	-1.1×	-84.3%	0.0%	0.0%	0.0%	-76.3%	-74.9%	-75.7%	0.1×	0.19×	0×	8.61×	0.0%	1	4.66	2	C+
ATYRaTyr Pharma, Inc.	$7.26	-0.98×	1.08×	383.2×	-1.02×	-128.4%	-717.4%	-40856.3%	-39009.5%	-109.8%	-96.5%	-85.2%	0.18×	-0.02×	0×	5.3×	0.0%	2	-14.23	2	C
BMEABiomea Fusion, Inc.	$0.60	-1.05×	2.19×	0×	-0.17×	48.4%	0.0%	0.0%	0.0%	-209.1%	-166.2%	-108.7%	0.05×	0.9×	0×	5.23×	0.0%	0	-18.95	2	C+
DTILPrecision BioSciences, Inc.	$10.73	-1.17×	0.58×	1.56×	0.68×	-257.3%	100.0%	-152.2%	-133.4%	-49.6%	-35.5%	-123.6%	0.31×	1.93×	-36.67×	13.32×	0.0%	3	-4.84	1	C-
Peer median	—	-1.05×	1.08×	0×	-0.5×	-90.6%	0.0%	0.0%	0.0%	-109.8%	-96.5%	-108.7%	0.18×	0.19×	0×	5.3×	0.0%	2	-4.84	2	—